Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Continuous Manufacturing as a Default Platform for Oral Solid Drug Products Lawrence De Belder, Senior Principal Engineer at j&J and Bob Lenich, Director of Life Sciences Business at Emerson Presented by Lawrence De Belder, Senior Principal Engineer Continuous Manufacturing at Johnson and Johnson Followed by an Industry Perspective presen... 3 years ago | 99 mins Continuous Manufacturing: Business Case Drivers and Deployment Strategies Lawrence De Belder, Senior Principal Engineer at Johnson and Johnson and Richard Steiner, Business Development Manager at GEA Continuous manufacturing for Oral Solid Dose drug products has the potential to generate benefits in many different areas of the product life cycle. I... 4 years ago | 81 mins A risk based approach to continuous processing Rob Bowen The article considers the opportunities for risk based change in facility design through quality by design (QbD) and advances in PAT. It suggests that... 8 years ago | 60 mins The Future of Pharmaceutical Manufacturing: Flexibility and Sustainability throu Daniel O. Blackwood & Jeffrey Moriarty of Pfizer, Inc. Following a decade (or more) of concerted effort by industry, regulator, and academic groups, recent technology investments are now beginning to shape... 5 years ago | 68 mins Using In-Vitro Dissolution to Support Post Approval Changes Global Regulatory Ex Dr Xin Bu, Principal Scientist, Bristol-Myers Squibb Dissolution is one of the critical quality attributes for solid oral dosage forms, typically tablets and capsules. In addition as a quality control (Q... 4 years ago | 43 mins A risk based approach to continuous processing Rob Bowen The article considers the opportunities for risk based change in facility design through quality by design (QbD) and advances in PAT. It suggests that... 8 years ago | 60 mins
